High Expression of JMJD4 Is a Potential Diagnostic and Prognostic Marker of Renal Cell Carcinoma

Figure 3

(a–e) Subgroup analysis of overall survival for patients in advanced Fuhrman grade, female patients, patients in T1 to T3 stage, patients age no greater than 60, and patients with low or normal hemoglobin. (f, g) Subgroup analysis of DSS for patients with ccRCC in female patients and patients age no greater than 60. (h) Subgroup analysis of PFI for patients with ccRCC in T1 to T3.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)